1.Analysis of a patient with early-onset retinitis pigmentosa due to novel variants of CRB1 gene.
Ming YI ; Dachang TAO ; Yuan YANG ; Yunqiang LIU
Chinese Journal of Medical Genetics 2023;40(9):1160-1164
OBJECTIVE:
To explore the genetic basis for a patient with early-onset retinitis pigmentosa (RP).
METHODS:
A patient who had presented at the West China Hospital of Sichuan University on March 10, 2020 was selected as the study subject. The patient and his parents were subjected to whole exome sequencing (WES). Candidate variants were verified by Sanger sequencing and in silico analysis.
RESULTS:
The patient has featured substantial loss of binocular vision field. Funduscopy revealed characteristic bone spicule-type pigment deposits, as well as attenuated retinal arterioles and pale-appearing optic discs. WES revealed that he has harbored compound missense variants of a RP-associated CRB1 gene, including c.2969T>C (p.Leu990Ser) and c.1816T>C (p.Cys606Arg), which were respectively inherited from his father and mother. Homozygous c.1816T>C (p.Cys606Arg) variant has been identified among RP patients, whilst the c.2969T>C (p.Leu990Ser) variant was unreported previously. Both variants were predicted as likely pathogenic based on the guidelines from the American College of Medical Genetics and Genomics (ACMG).
CONCLUSION
The novel compound heterozygous variants of the CRB1 gene probably underlay the early-onset RP in this patient. Above finding has enriched the mutational spectrum of the CRB1 gene.
Male
;
Female
;
Humans
;
China
;
Genomics
;
Homozygote
;
Mothers
;
Retinitis Pigmentosa/genetics*
;
Eye Proteins/genetics*
;
Membrane Proteins/genetics*
;
Nerve Tissue Proteins/genetics*
3.Molecular genetics of Kallmann syndrome: an update.
Chao FU ; Zheng FENG ; Rui-Zhi LIU
National Journal of Andrology 2011;17(4):361-365
Kallmann syndrome (KS) is a clinically and genetically heterogeneous disorder that occurs in either an inherited or a sporadic manner. KS results from failed embryonic migration of GnRH-1 neurons from the nasal placode to the hypothalamus, due to the abnormal development of olfactory nerves and bulbs. Hypogonadotropic hypogonadism is related to GnRH deficiency, and anosmia is associated with the absence or hypoplasia of olfactory bulbs and tracts. KS patients can also present some non-reproductive or non-olfactory anomalies in addition to the above typical symptoms. For the high complexity of the molecular genetic mechanism of KS, to date, only 6 KS-related genes have been identified. The KAL1 gene is responsible for the X chromosome-linked recessive form of KS, while the fibroblast growth factor receptor 1 (FGFR1/KAL2) and fibroblast growth factor 8 (FGF8/KAL6) genes are related to the autosomal dominant form of the disease. However, the mutations in these 6 genes account for only about 25 - 30% of all KS cases, which suggests that other pathogenic genes involved in KS remain to be discovered. This article presents an overview on the studies of the pathogenic genes, clinical diagnosis and treatment of KS.
Extracellular Matrix Proteins
;
genetics
;
Humans
;
Kallmann Syndrome
;
genetics
;
Mutation
;
Nerve Tissue Proteins
;
genetics
;
Receptor, Fibroblast Growth Factor, Type 1
;
genetics
4.Penetrance estimation of PRRT2 variants in paroxysmal kinesigenic dyskinesia and infantile convulsions.
Yulan CHEN ; Dianfu CHEN ; Shaoyun ZHAO ; Gonglu LIU ; Hongfu LI ; Zhi-Ying WU
Frontiers of Medicine 2021;15(6):877-886
Proline-rich transmembrane protein 2 (PRRT2) is the leading cause of paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), and infantile convulsions with choreoathetosis (ICCA). Reduced penetrance of PRRT2 has been observed in previous studies, whereas the exact penetrance has not been evaluated well. The objective of this study was to estimate the penetrance of PRRT2 and determine its influencing factors. We screened 222 PKD index patients and their available relatives, identified 39 families with pathogenic or likely pathogenic (P/LP) PRRT2 variants via Sanger sequencing, and obtained 184 PKD/BFIE/ICCA families with P/LP PRRT2 variants from the literature. Penetrance was estimated as the proportion of affected variant carriers. PRRT2 penetrance estimate was 77.6% (95% confidence interval (CI) 74.5%-80.7%) in relatives and 74.5% (95% CI 70.2%-78.8%) in obligate carriers. In addition, we first observed that penetrance was higher in truncated than in non-truncated variants (75.8% versus 50.0%, P = 0.01), higher in Asian than in Caucasian carriers (81.5% versus 68.5%, P = 0.004), and exhibited no difference in gender or parental transmission. Our results are meaningful for genetic counseling, implying that approximately three-quarters of PRRT2 variant carriers will develop PRRT2-related disorders, with patients from Asia or carrying truncated variants at a higher risk.
Dystonia
;
Epilepsy, Benign Neonatal/genetics*
;
Humans
;
Membrane Proteins/genetics*
;
Mutation
;
Nerve Tissue Proteins/genetics*
;
Pedigree
;
Penetrance
;
Seizures/genetics*
5.Advances in molecular genetics of schizophrenia.
Acta Academiae Medicinae Sinicae 2005;27(3):401-407
Schizophrenia (MIM 181500) is a complex disorder affecting approximately 1% of the population worldwide. Epidemiologic evidences, together with recent linkage and association studies, have clearly demonstrated the high heritability of schizophrenia (up to 80%). Uncovering the genetic mechanism of schizophrenia has became one of the greatest challenges for both psychiatry and genetics. In recent years, remarkable advances in the genetics of this disorder has been achieved with the rapid growth of human genome information and experiment technologies. Several candidate genes within some of the best-supported linkage regions have been reported and, more importantly, replicated. Moreover, these genes present a significant connection in the signaling pathways implicated in the development of schizophrenia, especially NMDA receptor-mediated glutamate transmission. In this review, we summarize the recent advances in the genetics of schizophrenia, focusing particularly on linkage disequilibrium analysis and the latest understanding of the neurobiology of the disorder.
Acyltransferases
;
genetics
;
Carrier Proteins
;
genetics
;
Dysbindin
;
Dystrophin-Associated Proteins
;
Humans
;
Membrane Proteins
;
genetics
;
Nerve Tissue Proteins
;
genetics
;
Neuregulin-1
;
Receptors, N-Methyl-D-Aspartate
;
genetics
;
Schizophrenia
;
genetics
6.A case of Allgrove syndrome with achalasia of cardia as its first clinical phenotype caused by a new mutation of AAAS gene.
Li Ya XIONG ; Pei Yu CHEN ; Jing XIE ; Lu REN ; Hong Li WANG ; Yang CHENG ; Pei Qun WU ; Hui Wen LI ; Si Tang GONG ; Lan Lan GENG
Chinese Journal of Pediatrics 2023;61(7):648-650
9.A pedigree with dentatorubralpallidolyysian atrophy.
Xingjiao LU ; Fei XIE ; Zhidong CEN ; Hongwei WU ; Xiaosheng ZHENG ; You CHEN ; Wei LUO
Chinese Journal of Medical Genetics 2017;34(6):934-935
10.Genetic testing and prenatal diagnosis of two pedigrees affected with Huntington disease.
Yilin REN ; Peng DAI ; Chen CHEN ; Huikun DUAN ; Xiangdong KONG
Chinese Journal of Medical Genetics 2021;38(5):446-449
OBJECTIVE:
To explore the genetic basis for two Chinese pedigrees affected with Huntington disease and provide prenatal diagnosis for them.
METHODS:
Peripheral venous blood samples were collected from the probands. PCR and capillary gel electrophoresis were used to determine the number of CAG repeats in their IT15 gene. Pre-symptomatic testing was offered to their children and relatives, and prenatal diagnosis was provided to three pregnant women from the two pedigrees.
RESULTS:
The two probands, in addition with three asymptomatic members, were found to have a (CAG)n repeat number greater than 40. Upon prenatal diagnosis, the numbers of CAG repeats in two fetuses from pedigree 1 were determined as (16, 19) and (18, 19), both were within the normal range. A fetus from pedigree 2 was found to have a CAG repeat number of (15, 41), which exceeded the normal range.
CONCLUSION
Genetic testing can facilitate the diagnosis of Huntington disease and avoid further birth of affected children.
Child
;
Female
;
Genetic Testing
;
Humans
;
Huntington Disease/genetics*
;
Nerve Tissue Proteins/genetics*
;
Pedigree
;
Pregnancy
;
Prenatal Diagnosis